Congratulations to TMS Co., LTD on Initial Public Offering!


TMS Co., LTD recently went public with an Initial Public Offering (IPO) of shares of common stock on the Tokyo Stock Exchange. TMS Co., LTD. is a pioneering, clinical stage biopharmaceutical company based in Tokyo, Japan. The aggregate proceeds of the global offering of 3,731,300 million shares of common stock will be about ¥2.9 billion ($20.5 million in U.S. dollars).

The Lathrop team provided intellectual property advice and was led by partner Laura Labeots, Ph.D. and included senior counsel Giulio DeConti and technical specialist Vinay Trivedi-Parmar, Ph.D. Members of the Lathrop team are based in the Chicago and Boston offices of Lathrop GPM.